Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2654

Actual shortage: 249 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2396 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-04-27 2024-04-25 190785
TEVA-MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-08 2023-06-27 194125
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-08 2023-07-12 194163
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-08 2024-01-08 194191
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-10-06 195078
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-07-05 195118
TEVA-MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-06-21 195210
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-20 2023-07-05 195763
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-20 2023-07-05 195827
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-04 2023-08-04 197169
TEVA-DILTIAZEM XC 240MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-19 2023-12-14 199199
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-21 2023-08-18 199554
TEVA-DILTIAZEM XC 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-21 2024-01-11 199717
TEVA-DILTIAZEM XC 180MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-12 2023-12-07 206904
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-11-03 2024-04-11 209148
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-09 2023-12-07 209672
ACT CLARITHROMYCIN XL 500MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-11 2024-04-11 215737
TEVA-DILTIAZEM XC 240MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-11 2024-04-25 215740
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-02-22 215743
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-02-22 215746

Showing 2601 to 2620 of 2654

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-12 2018-10-12 63943
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-19 2018-10-19 64891
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353

Showing 21 to 40 of 250